Skip to main content
. 2020 Mar;8(5):225. doi: 10.21037/atm.2020.01.17

Table 4. Clinical and laboratory characteristics of study subjects according to smoking history.

Variables Non-DM DM
Non-smoking (n=36) Smoking (n=16) P Non-smoking (n=28) Smoking (n=30) P
Age (years) 49.80±9.01 49.44±8.52 NS 48.93 ±9.73 45.90±10.56 NS
Male (%) 13 (36.1) 16 (100.0) 0.000 8 (28.6) 28 (93.3) 0.000
Hypertension medication (%) 5 (13.9) 2 (12.5) NS 5 (17.9) 6 (20.0) NS
Systolic BP (mmHg) 127±16 125±11 NS 139±21 132±16 NS
Diastolic BP (mmHg) 79±10 79±8 NS 83±12 78±11 NS
BMI (kg/m2) 23.47±5.20 23.43±2.81 NS 26.38±4.23 25.49±3.15* NS
FPG (mg/dL) 93.6±13.5 91.1±11.8 NS 175.4±48.0 177.9±42.4*** NS
Fasting insulin (µIU/mL) 8.71±4.31 7.79±4.38 NS 11.31±5.04 10.61±6.01 NS
Fasting C-peptide (pmol/mL) 0.66±0.33 0.67±0.10 NS 0.88±0.45 1.05±0.44*** NS
HOMA-IR 1.98±1.36 1.60±1.19 NS 4.89±2.27 4.58±2.67*** NS
HOMA-beta 104.67±54.56 104.87±64.90 NS 41.25±22.00 38.89±32.21*** NS
HbA1C (%) 5.4±0.2 5.5±0.2 NS 8.7±2.0 9.1±1.9*** NS
Total cholesterol (mg/dL) 200.9±40.7 184.6±33.6 NS 223.7±58.6 204.9±39.6 NS
HDL cholesterol (mg/dL) 57.0±13.9 55.3±11.8 NS 51.2±14.2 45.2±12.0* NS
LDL cholesterol (mg/dL) 126.6±37.2 113.1±32.5 NS 150.7±53.7 134.5±24.8 NS
Triglycerides (mg/dL) 128.5±107.3 111.1±53.9 NS 180.3±101.4 250.6±333.2 NS
hs-CRP (mg/L) 0.9±1.1 5.4±8.8 NS 2.1±4.0 2.1±2.6 NS
apoA (mg/L) 134.1±24.0 119.7±9.5 NS 128.3±31.8 96.5±17.8 NS
apoB (mg/L) 100.9±29.6 97.3±32.7 NS 119.1±20.4 111.5±23.5 NS
Framingham score (%) 2.7±3.3 8.0±3.9 0.000 3.4 (1.0–5.3) 10.3 (5.5–15.0) 0.000
IL-1beta (pg/mL) 18.3±6.3 18.8±4.4 NS 18.3±9.6 24.1±10.1* 0.030

Data are expressed as the mean ± SEM, or n (%). P value was calculated by independent Student t test or the Mann-Whitney U test. * compared between Non-DM and DM with smoking history. *, P<0.05; **, P<0.01; and ***, P<0.001. BP, blood pressure; BMI, body mass index; FPG, fasting plasma glucose; HOMA-IR, homeostasis model assessment-insulin resistance; HbA1c, hemoglobin A1c; HDL, high density lipoprotein; LDL, low density lipoprotein; hs-CRP, highly sensitive C-reactive protein; IL-1β, interleukin-1 β.